Black Rose Industries FY26 Earnings Webinar

Black Rose Industries Ltd. reported its financial results for the fiscal year ending March 31, 2026, during an earnings webinar on May 22, 2026.

Key Figures:

• Consolidated Revenue (FY26): Rs 3,258.52 crore (down 17.45% from FY25).
• Consolidated Profit After Tax (PAT) (FY26): Rs 211.98 crore (up 5.78% from FY25).

Reader Takeaway: Revenue declined due to price adjustments, but improved operational efficiencies boosted profitability.

Revenue Drops Amid Price Corrections, Profits Climb

Black Rose Industries reported a consolidated revenue of Rs 3,258.52 crore for FY26, a notable decrease from Rs 3,947.18 crore in FY25. Despite this revenue dip, the company's consolidated Profit After Tax (PAT) grew by 5.78% to Rs 211.98 crore, up from Rs 200.39 crore in the prior year. Standalone revenue also fell by 4.36% to Rs 3,258.38 crore, yet standalone PAT increased by 7.34% to Rs 209.58 crore. Both standalone and consolidated EBITDA saw positive movement, with standalone EBITDA rising 8.27% to Rs 327.27 crore and consolidated EBITDA up 8.02% to Rs 353.63 crore.

Why This Matters: Efficiency Outweighs Revenue Slump

These results highlight the company's strong cost management and margin improvement capabilities, even as revenue faced challenges. The rise in PAT and EBITDA signals effective operational efficiency and cost control measures. While the distribution revenue was impacted by price corrections and weaker merchant exports due to US tariffs, the manufacturing segment demonstrated resilience with increased volumes and better margins, fueled by new customer acquisitions and export growth.

Company Insights: Driving Factors

The company's distribution revenue was affected by general price corrections. In contrast, the manufacturing segment saw increased volumes for acrylamide liquid and NMA due to new customer wins and export opportunities. Acrylamide solid volumes remained stable. The company noted that its legacy businesses represent less than 1% of total revenue.

Outlook for FY27

Looking ahead to FY27, Black Rose Industries plans to concentrate on adding new products and expanding its customer base within chemical distribution. While a subdued demand is anticipated for Q1, the company expects merchant export volumes to increase. In the acrylamide sector, domestic demand is projected to pick up in the second half of FY27. The company will continue its focus on exports for liquid acrylamide and maintain stable volumes for solid acrylamide, with N-methylol acrylamide (NMA) expected to remain steady. Progress is also being made on the PAM solid project, moving towards piloting and developing new downstream acrylamide products. A decision regarding the Specialty Amines project is anticipated within the year.

Potential Risks

Near-term demand in chemical distribution might continue to be soft due to ongoing global uncertainties. Merchant exports face pressure from existing US tariffs. Fluctuations in Acrylonitrile (ACN) prices, a key raw material, could affect manufacturing costs and profit margins.

Key Financial Metrics

• Standalone EBITDA Margins improved to 10.0% in FY26 from 9.7% in FY25.
• Standalone PAT Margins improved to 6.4% in FY26 from 6.3% in FY25.
• Acrylonitrile (ACN) prices experienced fluctuations between April 2025 and March 2026.

What Investors Should Watch

Investors will be looking for the company's success in driving volume growth in distribution and leveraging export opportunities. Managing raw material price volatility will also be critical. Key developments to monitor include the progress of new projects like the PAM solid project and Specialty Amines, alongside the anticipated increase in domestic demand for acrylamide in the latter half of FY27.